Skip to content

What are the symptoms of atrophy during menopause?

5 min read

Affecting up to 50% of postmenopausal women, vulvovaginal atrophy is a common, yet often undertreated, condition. Understanding what are the symptoms of atrophy during menopause is the first step toward finding relief and improving your quality of life.

Quick Summary

The symptoms of atrophy during menopause, often called genitourinary syndrome of menopause (GSM), include vaginal dryness, burning, itching, and pain during intercourse. Urinary symptoms like urgency, frequency, and recurrent urinary tract infections are also common.

Key Points

  • Genitourinary Syndrome of Menopause (GSM): The preferred term for atrophic vaginitis, recognizing its impact on both vaginal and urinary health during menopause.

  • Vaginal Symptoms: Includes persistent dryness, burning, itching, and potential bleeding due to fragile vaginal tissues.

  • Urinary Symptoms: Can manifest as urinary urgency, frequent urination, and an increased susceptibility to recurrent urinary tract infections (UTIs).

  • Painful Intercourse (Dyspareunia): A common sign caused by decreased lubrication and elasticity, which can lead to tearing and spotting.

  • Risk Factors: Lifestyle factors like smoking, certain cancer treatments, and lack of sexual activity can increase the severity of atrophy symptoms.

  • Distinguishing from Other Conditions: It is crucial to differentiate GSM symptoms from those of infections like yeast infections or bacterial vaginosis, as treatments differ significantly.

In This Article

Understanding Genitourinary Syndrome of Menopause (GSM)

Menopause marks a significant transition in a woman's life, primarily defined by the decline of estrogen. This hormonal shift leads to numerous physical changes, one of the most impactful being genitourinary syndrome of menopause (GSM). Previously known as vulvovaginal atrophy (VVA), GSM is a chronic condition that results from the thinning, drying, and inflammation of the vaginal walls and urinary tract. As estrogen levels drop, the vaginal tissues become less elastic, less lubricated, and more fragile, which can lead to a constellation of uncomfortable and disruptive symptoms. Recognizing these symptoms is crucial for an accurate diagnosis and effective management.

The Prominent Vaginal Symptoms

Many women first notice GSM through changes in their vaginal health. These signs are often progressive and can worsen over time if left untreated. They are not simply a nuisance but can significantly impact a woman's sexual health and overall well-being. Identifying these issues can help women feel more in control of their health during menopause.

Vaginal Dryness

This is one of the most common and earliest indicators of atrophy. The natural moisture and lubrication of the vaginal lining diminish, leading to persistent dryness. This can cause significant discomfort in daily life, not just during sexual activity. Many women describe a feeling of rawness or irritation that is constant and distracting.

Vaginal and Vulvar Burning or Itching

As the vaginal tissue thins and loses its protective layers, it becomes more susceptible to irritation. This can result in a chronic burning or itching sensation in and around the vaginal opening. This symptom can be easily mistaken for a yeast infection, but it does not respond to typical antifungal treatments. A persistent, unexplained itch is often a sign of underlying atrophy.

Painful Intercourse (Dyspareunia)

Reduced lubrication and elasticity, coupled with the fragile vaginal walls, can make sexual activity painful. The thinning lining is more prone to minor tears and bleeding during intercourse, which can create a cycle of pain and anxiety surrounding intimacy. For some, this pain may become severe enough to cause them to avoid sexual activity altogether, straining relationships and affecting self-esteem.

Light Bleeding or Spotting

As mentioned, the delicate and thin vaginal lining can tear easily. This can lead to light bleeding or spotting, particularly after sexual intercourse or a gynecological exam. This symptom should always be evaluated by a healthcare provider to rule out other, more serious conditions.

Discharge

Some women with atrophy may experience a thin, watery, yellow, or grayish vaginal discharge. This is often due to the change in the vaginal pH balance, which can alter the vaginal flora and increase the risk of infections.

The Overlooked Urinary Symptoms

GSM is not limited to the vagina; it also affects the urinary tract, which is why the newer term is used. The same decline in estrogen that affects vaginal tissue also impacts the urethra and bladder, which are closely related anatomically. These urinary symptoms are often overlooked or attributed to aging, but they are a direct result of hormonal changes.

Urinary Urgency and Frequency

Many women with GSM feel a sudden, strong need to urinate, even when their bladder isn’t full. This urgency can be accompanied by an increase in how often they need to go. For some, this can lead to anxiety about being far from a bathroom, impacting social activities and daily routines.

Urge Incontinence

As the bladder lining loses elasticity, some women may experience involuntary leakage of urine, particularly when they feel the sudden urge to urinate. This can range from minor drips to more significant accidents and is a source of great embarrassment and distress.

Recurrent Urinary Tract Infections (UTIs)

Changes in the vaginal environment due to low estrogen increase the risk of bacterial growth and UTIs. Thinning of the urethral tissue can also make it more vulnerable to infection. Women with GSM may experience more frequent or persistent UTIs, even if they have never had them before.

Factors That Increase the Risk of Atrophy

Several factors can exacerbate or increase the likelihood of experiencing severe menopausal atrophy. Understanding these can help in risk management and targeted prevention.

  1. Surgical Menopause: The sudden, abrupt loss of ovarian function from the surgical removal of both ovaries can lead to more severe and immediate symptoms compared to natural menopause.
  2. Cancer Treatments: Radiation therapy to the pelvic area and chemotherapy can damage the ovaries and reduce estrogen production. Breast cancer treatments that suppress estrogen levels also contribute significantly.
  3. Smoking: Cigarette smoking reduces blood circulation and oxygen flow throughout the body, including the vaginal tissues, and can also interfere with estrogen production.
  4. Lack of Sexual Activity: Regular sexual activity, with or without a partner, can increase blood flow to the vaginal tissues, which helps to maintain elasticity and moisture. The lack of sexual activity can contribute to more severe atrophy over time.

Comparing Atrophy Symptoms with Other Conditions

When experiencing these symptoms, it can be easy to confuse them with other gynecological or urological issues. It is important to see a healthcare provider for an accurate diagnosis, as different conditions require different treatments.

Feature Atrophy (GSM) Yeast Infection Bacterial Vaginosis
Primary Cause Low estrogen levels Overgrowth of Candida fungus Overgrowth of certain bacteria
Discharge Thin, watery, yellow-gray Thick, white, cottage-cheese-like Thin, grayish-white with a fishy odor
Itching & Burning Persistent, generalized irritation Intense vulvar itching and burning Moderate, sometimes present
Onset Gradual onset post-menopause Sudden onset, often after antibiotics or hormonal changes Often linked to douching or new sexual partners
Associated Symptoms Urinary urgency, painful sex Pain during urination, soreness Pain during urination, vaginal odor
Relief from OTCs Little to no relief from typical yeast infection creams Often responds to OTC antifungal treatments Responds to specific prescription antibiotics

Conclusion

The symptoms of atrophy during menopause are part of a broader condition now known as GSM, affecting both vaginal and urinary health. Symptoms like vaginal dryness, burning, painful sex, and urinary issues are a direct result of declining estrogen. These issues are not simply an inevitable part of aging but are treatable conditions. By speaking with a healthcare provider and being open about your symptoms, you can explore various effective treatment options, including hormonal and non-hormonal therapies, to alleviate discomfort and restore quality of life. For more in-depth information, you can read about treatment options and management strategies at reputable health sources, such as the Mayo Clinic's guide on vaginal atrophy.

Frequently Asked Questions

Vaginal atrophy is characterized by symptoms such as persistent vaginal dryness, burning, itching, and pain during intercourse. You may also experience urinary symptoms like urgency and frequency. A doctor can confirm the diagnosis with a pelvic exam.

The primary cause is the sharp decline in estrogen production by the ovaries during perimenopause and after menopause. This reduction in estrogen leads to the thinning and drying of vaginal tissues.

Yes, for many women, the symptoms of atrophy are chronic and progressive. Without treatment, they often worsen over time, leading to increased discomfort and potential complications like more frequent urinary tract infections.

Non-hormonal treatments include over-the-counter vaginal lubricants for immediate relief of dryness during sex and long-term vaginal moisturizers. Regular sexual activity can also help maintain blood flow and tissue elasticity.

Yes, a doctor's visit is recommended for a proper diagnosis. It's important to rule out other conditions like infections and to discuss the most effective treatment plan, which may include low-dose vaginal estrogen.

Atrophic vaginitis is caused by low estrogen, while a yeast infection is caused by a fungal overgrowth. While both cause irritation and burning, discharge from atrophy is typically thin, watery, or yellow-gray, whereas yeast infections produce a thick, white, 'cottage cheese' discharge.

Systemic HRT can help alleviate atrophy symptoms, but low-dose vaginal estrogen therapy is often highly effective with fewer systemic side effects, as it targets the vaginal tissue directly. Your doctor can help you determine the best option.

References

  1. 1
  2. 2
  3. 3

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.